Cortexyme Company
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical
Technology:
Gene therapy
Funding Status:
IPO
Investment Stage:
N/A
Estimated Revenue:
$10M to $50M
Investors Number:
13
Headquarters:
South San Francisco, California, United States
Employee Number:
11-50
Number Of Exists:
N/A
Investor Type:
N/A
Total Funding:
225000000
Founded Date:
2012
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2019